Research and Markets: Global Gastrointestinal Stromal Tumor Epidemiology and Patient Flow Analysis - 2012

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/gtczdk/global) has announced the addition of the "Global Gastrointestinal Stromal Tumor Epidemiology and Patient Flow Analysis - 2012" report to their offering.

Fore Pharma announced the results of its Gastrointestinal Stromal Tumor patient population study in a new report Global Gastrointestinal Stromal Tumor Epidemiology and Patient Flow Analysis - 2012'. The report provides insights into Gastrointestinal Stromal Tumor epidemiology, Gastrointestinal Stromal Tumor diagnosed patients, and Gastrointestinal Stromal Tumor treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Gastrointestinal Stromal Tumor derived from epidemiological analysis, percentage of patients diagnosed with Gastrointestinal Stromal Tumor, and percentage of patients treated with Gastrointestinal Stromal Tumor therapy.

The study helps executives estimate Gastrointestinal Stromal Tumor market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Gastrointestinal Stromal Tumor prevalence, Gastrointestinal Stromal Tumor diagnosis rate, and Gastrointestinal Stromal Tumor treatment rate for the period 2012-2019. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.

Key Features of the Report:

- Gastrointestinal Stromal Tumor: Disease Definition

- Gastrointestinal Stromal Tumor Patient Flow

- Gastrointestinal Stromal Tumor Prevalence

- Gastrointestinal Stromal Tumor Diagnosed Patients

- Gastrointestinal Stromal Tumor Treated Patients

For more information visit http://www.researchandmarkets.com/research/gtczdk/global

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals